Diasorin · 18 hours ago
Intern, IT (End User Support)
Diasorin is a global leader in diagnostic solutions, dedicated to improving healthcare worldwide. The IT Intern will support internal users by building and deploying PC infrastructure and providing daily end-user support, contributing to the company's mission of enhancing patient care.
BiotechnologyHealth Diagnostics
Responsibilities
Deliver key tasks and projects that provide to our broader mission of the organization, and how we have an impact on patients’ lives
Collaborate with fellow interns and employees through various onsite and offsite activities
Gain industry knowledge that will aid in your professional development, while showcasing your learnings and accomplishments to Senior leaders and fellow colleagues
Support all aspects of the hardware and applications our internal users rely on to perform their critical activities
Build and deploy the PC infrastructure users interact with daily
Provide daily support to the end user
Qualification
Required
Pursuing a Bachelor's Degree in an IT related program
Currently enrolled in a University or College Program that is accredited. Recent graduates may be considered
Must be enrolled in or have completed courses related to field of interest
Knowledge of Microsoft Office
Attention to Detail
Being A Team Player
Operating with Professionalism
Coursework related to the IT field
Benefits
Comprehensive plan of health benefits
Retirement and financial wellbeing
Time off programs
Wellbeing support and perks
Annual incentive program
Company
Diasorin
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics
H1B Sponsorship
Diasorin has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2022 (1)
Funding
Current Stage
Late StageRecent News
2026-02-04
2026-01-23
Company data provided by crunchbase